Benzinga | Aug 6, 2020 07:32AM EDT

Corbus Pharmaceuticals Q2 EPS $(0.52) Misses $(0.39) Estimate

Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(0.52) per share which missed the analyst consensus estimate of $(0.39) by 33.33 percent. This is a 1833.33 percent decrease over earnings of $0.03 per share from the same period last year.